Close Menu

University of Kansas

Core labs remain closed or at reduced operations due to the COVID-19 pandemic, leading to concerns about the state of their businesses when they can reopen.

The team will present the results to the US Food and Drug Administration as part of a 510(k) application in order to commercialize the technology with Biofluidica.

With several SBIR grants from the NIH, the firm is also using its Liquid Scan platform to identify neonatal trophoblast cells in maternal blood samples.

Research groups and companies are developing and applying tools to enrich for and capture CTCs to diagnose tumors early and monitor patients during treatment.

Mountain chickadee

Researchers used thousands of conserved sequences for more than 100 songbird species to reconstruct their diversification and historical expansion route.

Genomic, transcriptomic, and phylogenetic data suggest a group of microscopic parasites within the cnidarian lineage has undergone extensive body plan streamlining.

The partners will collaborate on pediatric oncology research, with a goal of earning an NCI designation of Comprehensive Cancer Center.

The NCRR funding will fund clinical and translational science centers and partnerships centered at five universities.

NHGRI's rare diseases program will partner with The University of Kansas and the Leukemia and Lymphoma Society to speed up therapeutic development.

According to unaudited, pro forma data, Panomics would have added $10.7 million to Affy's total revenues for the nine months ended Sept. 30, 2008, and $11 million to the company's top line in fiscal year 2007.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.